Baxter International Inc (BAX) : Cssil added new position in Baxter International Inc during the most recent quarter end. The investment management firm now holds 715,000 shares of Baxter International Inc which is valued at $34,741,850 , the company said in a statement filed on Aug 15, 2016 with the SEC.Baxter International Inc makes up approximately 4.70% of Cssil’s portfolio.
Other Hedge Funds, Including , Putnam Investments reduced its stake in BAX by selling 397,448 shares or 40.44% in the most recent quarter. The Hedge Fund company now holds 585,389 shares of BAX which is valued at $28,444,052. Baxter International Inc makes up approx 0.07% of Putnam Investments’s portfolio.Omers Administration Corp reduced its stake in BAX by selling 879 shares or 1.01% in the most recent quarter. The Hedge Fund company now holds 86,221 shares of BAX which is valued at $4,189,478. Baxter International Inc makes up approx 0.09% of Omers Administration Corp’s portfolio.Concert Wealth Management boosted its stake in BAX in the latest quarter, The investment management firm added 2,454 additional shares and now holds a total of 15,882 shares of Baxter International Inc which is valued at $762,654. Baxter International Inc makes up approx 0.10% of Concert Wealth Management’s portfolio.Lmr Partners Llp reduced its stake in BAX by selling 472,766 shares or 95.43% in the most recent quarter. The Hedge Fund company now holds 22,649 shares of BAX which is valued at $1,087,605. Baxter International Inc makes up approx 0.16% of Lmr Partners Llp’s portfolio.W.g. Shaheen Associates Dba Whitney Co reduced its stake in BAX by selling 7,845 shares or 59.91% in the most recent quarter. The Hedge Fund company now holds 5,250 shares of BAX which is valued at $243,180. Baxter International Inc makes up approx 0.10% of W.g. Shaheen Associates Dba Whitney Co’s portfolio.
Baxter International Inc closed down -0.55 points or -1.18% at $46.18 with 42,49,317 shares getting traded on Thursday. Post opening the session at $46.75, the shares hit an intraday low of $45.91 and an intraday high of $46.78 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Baxter International Inc reported $0.46 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 26, 2016. Analyst had a consensus of $0.40. The company had revenue of $2585.00 million for the quarter, compared to analysts expectations of $2516.16 million. The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Jul 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 50 from a previous price target of $47 .Baxter International Inc was Resumed by JP Morgan to “Neutral” on Jun 6, 2016.
Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.